Shares of Wockhardt slipped 4 percent intraday on Wednesday as it has been failing to meet health regulators' standards. In a latest, the US Federal Drug Administration (US FDA) has said that management of the drug major company has deleted key trial data from hard drives, reports CNBC-TV18. It raises concerns about integrity of data the company has generated. The US FDA has said that it is concerned about Wockhardt's responses to the health regulator's queries and lab records are not in compliance with established standards.
Help employers find you! Check out all the jobs and post your resume.
